Misuse and abuse of quetiapine
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Kwetiapina jest atypowym lekiem przeciwpsychotycznym, często stosowanym w psychiatrii, w tym również objawowo do leczenia innych zaburzeń niż we wskazaniach rejestracyjnych. Jednym z zastosowań jest łagodzenie stanów klinicznych powodowanych używaniem różnych substancji psychoaktywnych. W pracy przedstawiono i omówiono doniesienia o niewłaściwym używaniu kwetiapiny, nadużywaniu, a nawet uzależnieniu psychicznym, a także o objawach zbliżonych do tak zwanego zespołu dyskontynuacji, często mylonego z zespołem abstynencyjnym występującym w przebiegu uzależnienia. Na podstawie analizy przedstawionych przypadków wykazano, że większość doniesień dotyczy mężczyzn, szczególnie nadużywających lub uzależnionych od innych, najczęściej licznych substancji psychoaktywnych, a także z zaburzeniami osobowości, często pozostających w konflikcie z prawem. Z tego względu należy pamiętać o ostrożności w przepisywaniu kwetiapiny tym osobom. W artykule dyskutowane są potencjalne mechanizmy, które mogą prowadzić do niewłaściwego używania kwetiapiny. Jest to prawdopodobnie związane z działaniem sedatywnym i przeciwlękowym co powoduje jej częste stosowanie z substancjami pobudzającymi. Również wysokie powinowactwo do receptora H 1 może powodować działanie nagradzające, podobnie jak leki przeciwhistaminowe.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Valeriani et al [55] carried out a range of exploratory qualitative searches of 163 discussion fora/specialized websites, and found that misusers may ingest olanzapine to treat unwanted 'comedown' symptoms (depression, dysphoria, anxiety, and insomnia) from drug/alcohol intake [56], although olanzapine withdrawal symptoms have been described as well [37; 54].”
Citations
Cites
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
Horacek, J., Bubenikova-Valesova, V., Kopecek, M., Palenicek, T., Dockery, C., Mohr, P., & H??schl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 461
Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations
Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00255.x · Cited by 328
Pierre, J. M., SHNAYDER, I., Wirshing, D. A., & Wirshing, W. C. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1718 · Cited by 102 · cited 5×
“In one of the prisons 30% of inmates simulated psychotic symptoms (auditory hallucinations, paranoid delusions) to swindle quetiapine [7].”
BackgroundInfluentialEffects of the histaminergic system on the morphine-induced conditioned place preference in mice
Suzuki, T., Takamori, K., Misawa, M., & Onodera, K. (1995) · Brain Research · doi:10.1016/0006-8993(95)00064-w · Cited by 80 · cited 1×
“Thus, quetiapine, just as antihistamines, may have reward properties,same as psychostimulant substances [35, 36, 37].”
BackgroundRisk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
Mullins, C. D., Obeidat, N. A., Cuffel, B. J., Naradzay, J., & Loebel, A. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.035 · Cited by 79 · cited 2×
“ation syndrome” [22, 26] or “rebound symptoms”.”
BackgroundHUSSAIN, M. Z., WAHEED, W., & HUSSAIN, S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1755-a · Cited by 72 · cited 4×
“Another high-risk population are prisoners and persons with criminal records [7, 9, 16, 20, 30], and in some prisons it is a widespread phenomenon [7].”
BackgroundInfluentialIntravenous Quetiapine-Cocaine Use ("Q-Ball")
WATERS, B. M., & Joshi, K. G. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.173a · Cited by 67 · cited 6×
“However, that is characteristic that almost all reported cases concerned people abusing other substances in the past or being addicted to them [8-10, 12, 14, 20, 27, 28].”
BackgroundInfluentialPatterns of Quetiapine Use in Psychiatric Inpatients: An Examination of Off-Label Use
Philip, N. S., Mello, K., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230701866870 · Cited by 64 · cited 2×
“In addition to clinical cases of misuse /abuse/ addictive use of quetiapine, the fact that quetiapine is commonly prescribed for indications other than for which it is registered (approximately 70% of all prescriptions) is striking [1-3].”
BackgroundMisuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse
Malekshahi, T., Tioleco, N., Ahmed, N., Campbell, A. N. C., & Haller, D. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.006 · Cited by 53 · cited 1×
“In most cases, these drugs have been used to cope with withdrawal symptoms or to increase the effectiveness of alcohol or other substances, and not as a “leading” substance [6].”
BackgroundIs seroquel developing an illicit reputation for misuse/abuse?
Sansone, R. A., & Sansone, L. A. (2010) · PubMed · Cited by 52
Some behavioral effects of histamine H1 antagonists in squirrel monkeys.
Bergman, J., & Spealman, R. D. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23894-0 · Cited by 50 · cited 1×
“Thus, quetiapine, just as antihistamines, may have reward properties,same as psychostimulant substances [35, 36, 37].”
BackgroundQuetiapine: Treatment for substance abuse and drug of abuse
Hanley, M. J., & Kenna, G. A. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070112 · Cited by 45 · cited 2×
“Very often quetiapine is used in the treatment of various disorders due to psychoactive substance use, including the treatment of affective and psychotic disorders associated with comorbid abuse or addiction to them [4, 5].”
BackgroundSankaranarayanan, J., & Puumala, S. E. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.04.017 · Cited by 44
Additional Evidence of the Abuse Potential of Quetiapine
Reeves, R. R., & Brister, J. C. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e3180f62d53 · Cited by 44 · cited 7×
“He insisted on the implementation of 400 mg/d of quetiapine per day [16].”
BackgroundInfluentialPossible intranasal quetiapine misuse
Morin, A. K. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060226 · Cited by 43 · cited 3×
“However, that is characteristic that almost all reported cases concerned people abusing other substances in the past or being addicted to them [8-10, 12, 14, 20, 27, 28].”
BackgroundAddictive Potential of Quetiapine
MURPHY, D., BAILEY, K., STONE, M., & WIRSHING, W. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020277 · Cited by 39 · cited 4×
“[19] presented a case of a 29-year-old man who came to the emergency room claiming that he suffered from schizophrenia and was treated with quetiapine.”
BackgroundInfluentialOff-label prescription of quetiapine in psychiatric disorders
Rowe, D. L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.841 · Cited by 39
Low‐Dose Quetiapine Is Not a Benign Sedative‐Hypnotic Agent
Gugger, J. J., & Cassagnol, M. (2008) · American Journal on Addictions · doi:10.1080/10550490802266185 · Cited by 35 · cited 1×
“For example, Gugger and Cassagnoi do not suggest the restriction in prescribing low doses of quetiapine, but think that the knowledge that the drug is not as safe as previously reported should be spreaded [40].”
BackgroundThe safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
Twaites, B. R., Wilton, L. V., & Shakir, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107073257 · Cited by 34
Black-Market Value of Antipsychotics, Antidepressants, and Hypnotics in Las Vegas, Nevada
TARASOFF, G., & OSTI, K. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.350 · Cited by 31 · cited 3×
“It seems that one of the main objectives of the use of quetiapine is coping with such symptoms as anxiety and insomnia [32].”
BackgroundInfluentialQuetiapine Discontinuation Syndrome
Kim, D. R., & Staab, J. P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.1020 · Cited by 29 · cited 3×
“” A similar case has been interpreted by Kim and Staab [22], as “a quetiapine discontinuation syndrome”.”
Background[Quetiapine in substance use disorders, abuse and dependence possibility: a review].
Erdoğan, S. Ö. (2010) · PubMed · Cited by 27
Quetiapine: Another Drug With Potential for Misuse? A Case Report
Paparrigopoulos, T., Karaiskos, D., & Liappas, J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0122a · Cited by 25 · cited 3×
“The knowledge of specific risk groups (people abusing or dependent on other substances, particularly on many substances, people with personality disorders, prisoners and men) requires special care in prescribing quetiapine [15, 39] and then monitoring possible misuse / abuse / addicting use.”
BackgroundInfluentialMcLarnon, M. E., Fulton, H. G., MacIsaac, C., & Barrett, S. P. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182670648 · Cited by 25
A Possible Case of Quetiapine Withdrawal Syndrome
Thurstone, C. C., & Alahi, P. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0810e · Cited by 20 · cited 4×
“Sometimes the discontinuation syndrome occurred at low doses of quetiapine [21] and substance seeking typical for dependence is rare [34].”
BackgroundInfluentialIs quetiapine a drug of abuse? Reexamining the issue of addiction
Tcheremissine, O. V. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802496883 · Cited by 19 · cited 1×
“Tcheremissine [41] is even more moderate.”
Quetiapine Dependence and Withdrawal: A Case Report
Yargıç, İ., & Caferov, C. (2011) · Substance Abuse · doi:10.1080/08897077.2011.558448 · Cited by 16 · cited 2×
“The case reported by Yargica and Caferova [27] refers to the 37-year-old man addicted to alcohol.”
BackgroundDependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression
Chen, C., Shiah, I., Lee, W., Kuo, S., Huang, C., & Wang, T. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01953.x · Cited by 16 · cited 2×
“However, that is characteristic that almost all reported cases concerned people abusing other substances in the past or being addicted to them [8-10, 12, 14, 20, 27, 28].”
BackgroundReversible withdrawal dyskinesia associated with quetiapine
Michaelides, C., Thakore‐James, M., & Durso, R. (2005) · Movement Disorders · doi:10.1002/mds.20427 · Cited by 15 · cited 3×
“In addition, in the presented cases, the discontinuation syndrome was atypical or non-specific and caused diagnostic difficulties or even errors [24], and thus delayed proper treatment.”
BackgroundLess Abuse Potential with XR Formulation of Quetiapine?
Reccoppa, L. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00104.x · Cited by 11
A case report of quetiapine withdrawal syndrome in a geriatric patient
Kohen, I., & Kremen, N. J. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701639437 · Cited by 7
Reversible hyperkinetic movement disorder associated with quetiapine withdrawal
Ahmad, M. T., & Prakash, K. M. (2010) · Movement Disorders · doi:10.1002/mds.23089 · Cited by 6
Cited by
Multi-Target Approach for Drug Discovery against Schizophrenia
Kondej, M., Stępnicki, P., & Kaczor, A. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103105 · Cited by 110
“Moreover, there are reports about quetiapine misuse and abuse which can be linked with its high affinity for the H1 receptor, as antihistamines agents cause rewarding action, compare Figure 3 [96].”
BackgroundGjerden, P., Bramness, J. G., Tvete, I. F., & Slørdal, L. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2281-8 · Cited by 48
Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000814 · Cited by 44
Nigović, B., Mornar, A., & Sertić, M. (2016) · Microchimica Acta · doi:10.1007/s00604-016-1781-z · Cited by 38
“QTP has become one of the highest-selling medications and the most abused antipsychotic [2].”
BackgroundQuetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review
Vento, A. E., Kotzalidis, G. D., Cacciotti, M., Papanti, G. D., Orsolini, L., Rapinesi, C., Savoja, V., Calabrò, G., CASALE, A. D., Piacentino, D., et al. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1668013 · Cited by 36
Metadata
- Authors
- Piróg-Balcerzak, A., Habrat, B., & Mierzejewski, P.
- Affiliations
- Institute of Psychiatry and Neurology (PL)
- Corresponding author
- Piróg-Balcerzak, Agnieszka
- Venue
- Psychiatria Polska
- Published
- 2015-02-24
- Volume
- 49
- Issue
- 1
- Pages
- 81-93
- ISSN
- 0033-2674 (ISSN-L)
- 2391-5854
- OpenAlex
- W2133759844
- Cited by
- 21
- References
- 33
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1
- FWCI
- 1.35
- Type
- journal article
- Language
- pl
- Open access
- diamond
- doi.org
- Locations
- Psychiatria Polska (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- quetiapine, misuse, abuse, drug addiction, withdrawal syndrome, dissociation, substance use disorders, personality disorders, sedative-hypnotic effects, anxiolytic effects, H1 receptor antagonism, antipsychotic prescribing
- MeSH terms
- Quetiapine Fumarate, Bipolar Disorder, Dibenzothiazepines, Humans, Schizophrenia, Substance Withdrawal Syndrome, Antipsychotic Agents, Substance-Related Disorders, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.